Objective -To assess the inflammatory status in dogs with uremia by measuring the 19 expression of inflammatory cytokines and enzymes in venous whole blood. 
5 al. 13 detected that patients with AKI had significantly higher plasma levels of IL-1β, IL-6, IL-90 8, TNF-α, CRP and IL-10 compared to healthy people and patients with CKD. Additionally 91 IL-6 and IL-8, but also the anti-inflammatory IL-10 were significantly higher in nonsurvivors. 92
In other studies it was shown that IL-2, IL-6 and TNF-α were markedly higher in patients 93 with AKI and were also significantly related with mortality rates 14, 15 . 94 LO5 is primarily expressed in leukocytes and is the key enzyme in leukotriene biosynthesis, 95 which are considered potent mediators of inflammation 16 . The LOX enzymes have also been 96 implicated in renal vasoconstriction and inflammation in AKI and lipoxygenase interaction 97 products (lipoxins) have shown to be beneficial in AKI 17, 18 . One of the key enzymes 98 generating nitric oxide from l-arginine is iNOS. iNOS-derived nitric oxide plays an important 99 role in inflammatory conditions. In rats an increase in iNOS simultaneously with the major 100 damage to the kidney was evidenced after induced ischemic AKI 19 . 101
We hypothesized first, that based on human medicine and experimental studies uremia is an 102 inflammatory condition in dogs. Second, that the degree of inflammation correlates with the 103 severity of azotemia and third, that the degree of inflammation is more pronounced in dogs 104 with acute kidney injury compared to dogs with chronic kidney disease. 105 106 107
Materials and Methods 108 109
Between the study period from January 1, 2010 to December 31, 2010 all dogs presenting 110 with azotemia due to either AKI or stable CKD to the small animal clinic of the Vetsuisse 111 faculty in Bern, Switzerland were considered for this prospective study. All dogs enrolled in 112 this study were also part of another study that focused on the dogs with leptospirosis-113 associated pulmonary hemorrhage syndrome.
a AKI was defined as the occurrence of acute 114 onset of renal azotemia and compatible historical, clinical, clinicopathological and6 radiological findings. CKD was defined as presence of stable azotemia for at least 3 months 116 duration, inability to concentrate urine and compatible findings in abdominal ultrasonography. 117 Exclusion criteria included known or suspected acute-on-chronic kidney disease, unstable 118 CKD, glomerulonephritis, pre-and postrenal causes of azotemia. 46 dogs met the entry 119 criteria for AKI, and 8 for CKD. In this population, AKI was mainly due to leptospirosis 120 (69.6%), but also grape ingestion (6.5%), other intoxications (4.3%) and AKI of unknown 121 origin (19.6%). Dogs with AKI were classified into five different grades as proposed by 122 Ten clinically healthy control dogs from staff or volunteering owners were also evaluated. 133
Their health evaluation included physical examination, complete blood count, chemistry, and 134
urinalysis. 135 136
Demographic and laboratory characteristics (complete blood count, chemistry, urinalysis) 137 were evaluated for every dog. For the purpose of this study, the expression of the anti-138 inflammatory cytokines IL-10 and TGF-β, as well as the pro-inflammatory cytokines IL-1α, 139 IL-1β, IL-8 and TNF-α were measured at initial presentation using venous whole blood. 140
Additionally the enzymes LO5 and iNOS were also evaluated. Analysis of each cytokine and7 enzyme was done measuring mRNA expression by RT-PCR as described in detail 142 previously.
a Shortly, mRNA was extracted from whole blood using a commercially available 143 kit b , according to the manufacturer's protocol. Before RT-PCR, RNA was converted to cDNA 144 using a synthesis kit c . Specific primers were used as previously described. a . The RT-PCR 145 assay was developed and evaluated on a real-time DNA detection system d . mRNA levels were 146 calculated relative to the housekeeping gene ubiquitin, which was used as a control. This 147 study was approved by the animal experimental ethics committee of the Small animal 148 teaching hospital of the Vetsuisse faculty University of Bern. 149
150
The statistical analysis was performed with a commercial software.
e Since most data were not 151 normally distributed, non-parametric statistics were used. Continuous data were compared 152 with the Mann-Whitney rank-sum test. Regression analysis was performed using the 153 The dogs in the AKI group ranged in age from 2 months to 12.3 years (median, 4.8 years), 161 the dogs in the CKD group ranged from 9 months to 10.6 years (median, 6.5 years) and the 162 dogs in the healthy group ranged in age from 1 to 11.1 years (median, 3.9 years). In the AKI 163 group, one dog was classified as grade I, 10 dogs as grade IV and 16 dogs as grade V. In the 164 CKD group, one dog was classified as IRIS stage 3 and the remaining seven dogs as IRIS 165 stage 4. Baseline clinicopathological characteristics for all dogs are presented in table 1. 166
Packed cell volume was markedly higher in AKI compared to CKD, healthy dogs compared 167 8 to AKI and healthy dogs compared to CKD. The platelets were markedly lower in AKI 168 compared to healthy dogs. White blood cell counts were elevated in AKI compared to CKD 169 and healthy dogs. Urea and creatinine were also markedly elevated in AKI compared to 170 healthy dogs and in CKD compared to healthy dogs. 171
Azotemic dogs (AKI and CKD) had marked increases in blood mRNA levels of the cytokines 172 IL-1α (P < 0.00004), IL-1β (P < 0.00097), TGF-β (P < 0.0049) and the enzyme LO5 (P < 173 The kidney is a site of both TGF-β production and TGF-β action. It is well known that TGF-β 212 plays a key role in chronic progressive renal disease not only mediating fibrogenesis but also 213 apoptosis and epithelial-to-mesenchymal transdifferentiation 25 . Increased expression in our 214 CKD population is therefore not surprising. In our animals with AKI, TGF-β was also 215 significantly higher compared to CKD dogs. In an experimental rat model with induced 216 ischemic AKI, TGF-β was elevated within 3 days and remained elevated for up to 7 days. The 217 role of TGF-β in AKI is not completely clear, but TGF-β activity appears to influence cellular 218 proliferation after the initial insult, although clear evidence is lacking that TGF-β plays a 219 substantial role in renal repair response. Contrary to that, TGF-β activity promotes renal 220 fibrogenesis and renal blood vessel loss following AKI and therefore may predispose the 221 kidney for the development of CKD 26 . 222
It is unclear why other inflammatory cytokines such as TNF-α that have been implicated 223 several times to be elevated in experimental models but also clinical studies with AKI were 224 not different between azotemic and healthy animals in our study. Also, no correlation could 225 be detected between individual laboratory parameters, especially degree of azotemia and 226 cytokine gene expression. Additionally, with the exception of TGF-β no difference could be 227
shown between dogs with AKI and CKD. 228
Potential explanations include the timing of cytokine determination in the overall course of 229 disease. The time between onset of clinical signs and presentation to our hospital varied 230 among dogs with AKI. It is therefore possible that differences in expression of early and late 231 inflammatory markers may have been missed. It is also important to remember that 232 inflammatory cytokine and enzyme biology is very complex in disease states and a lack of 233 correlation between gene expression of cytokines and their bioactivity has been 234 demonstrated 27 . Of course this hypothesis should be confirmed with the measurement of 235 cytokine plasma levels. In some diseases, measurement of cytokines in other tissues than 236 plasma might be useful. As an example, measurement of urinary cytokine IL-6 better reflects 237 the disease state than circulating plasma IL-6 28 and also measurement of inflammatory 238 cytokines in bronchial alveolar lavage fluid has better prognostic value than in plasma 29, 30 . It 239 also has to be taken into account that in the majority of experimental studies of AKI, 240 cytokines were measured directly in the kidney tissue. This procedure is not without risk and 241 therefore not as routinely performed in veterinary medicine as it is in human medicine. Maybe 242 measuring cytokine expression in urine instead of plasma would have given us a clearer 243 picture about the inflammatory process in AKI, but since most of our dogs are oligo-anuric, 244 this might not have been possible in most of the cases. 245
Other reasons might be, that the differences in plasma cytokine expression between the 246 groups are too small to get detected by the methods used in this study or that variations are 247 due to the heterogeneity of the disease groups. A similar observations has been made in 248
another study for plasma levels of IL-1β 31 . Other limitations would be the sample size in our 249
groups; however the power should be sufficient to detect major, clinically relevant 250 differences. Another point is that the degree of inflammation is certainly multifactorial and 251 caused by a combination of primary (etiology) and secondary (complications) parameters. 252
Since the inflammatory process is very complex it is possible that different biomarkers than 253 the ones we used would better represent inflammation in AKI. IL-6 is an important pro-254 inflammatory cytokine in the kidney and its release is stimulated by TNF-α. In several studies, 255 plasma IL-6 levels have been shown to be increased in patients with AKI and could also be 256 used to predict mortality 13, 15, 31, 32 . In addition, urinary IL-6 has been proposed as an early 257 marker for acute renal allograft rejection 33 . Furthermore, IL-18 which is a pro-inflammatory 258 cytokine induced in the proximal tubule after injury, seems to be a potential biomarker for 259 AKI. Urinary IL-18 levels were not only increased in mice with ischemic AKI but also in 260 human patients with acute tubular necrosis and delayed graft function compared with other 261 renal diseases 34 . Several studies demonstrated, that IL-18 could not only be used as a good 262 marker for early detection of AKI, but also to predict mortality risk after AKI 35 . 263
In conclusion, a clear increase could be detected in the blood mRNA expression of the 264 cytokines IL-1α, IL-1β, TGF-β and the enzyme LO5 in azotemic dogs, suggesting that these 265 markers are part of an inflammatory response seen with acute or chronic kidney injury. 
